COGT
Price
$7.10
Change
-$0.23 (-3.14%)
Updated
Jun 27 closing price
Capitalization
808.95M
45 days until earnings call
RARE
Price
$36.52
Change
-$0.91 (-2.43%)
Updated
Jun 27 closing price
Capitalization
3.45B
32 days until earnings call
Interact to see
Advertisement

COGT vs RARE

Header iconCOGT vs RARE Comparison
Open Charts COGT vs RAREBanner chart's image
Cogent Biosciences
Price$7.10
Change-$0.23 (-3.14%)
Volume$5.32M
Capitalization808.95M
Ultragenyx Pharmaceutical
Price$36.52
Change-$0.91 (-2.43%)
Volume$2.68M
Capitalization3.45B
COGT vs RARE Comparison Chart in %
Loading...
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RARE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
COGT vs. RARE commentary
Jun 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COGT is a Buy and RARE is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 29, 2025
Stock price -- (COGT: $7.10 vs. RARE: $36.52)
Brand notoriety: COGT and RARE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COGT: 309% vs. RARE: 260%
Market capitalization -- COGT: $808.95M vs. RARE: $3.45B
COGT [@Biotechnology] is valued at $808.95M. RARE’s [@Biotechnology] market capitalization is $3.45B. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COGT’s FA Score shows that 0 FA rating(s) are green whileRARE’s FA Score has 0 green FA rating(s).

  • COGT’s FA Score: 0 green, 5 red.
  • RARE’s FA Score: 0 green, 5 red.
According to our system of comparison, COGT is a better buy in the long-term than RARE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COGT’s TA Score shows that 4 TA indicator(s) are bullish while RARE’s TA Score has 3 bullish TA indicator(s).

  • COGT’s TA Score: 4 bullish, 6 bearish.
  • RARE’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, COGT is a better buy in the short-term than RARE.

Price Growth

COGT (@Biotechnology) experienced а -1.80% price change this week, while RARE (@Biotechnology) price change was -1.67% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

COGT is expected to report earnings on Aug 12, 2025.

RARE is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RARE($3.45B) has a higher market cap than COGT($809M). COGT YTD gains are higher at: -8.974 vs. RARE (-13.192). COGT has higher annual earnings (EBITDA): -284.04M vs. RARE (-449.9M). RARE has more cash in the bank: 494M vs. COGT (246M). COGT has less debt than RARE: COGT (17.1M) vs RARE (38.3M). RARE has higher revenues than COGT: RARE (591M) vs COGT (0).
COGTRARECOGT / RARE
Capitalization809M3.45B23%
EBITDA-284.04M-449.9M63%
Gain YTD-8.974-13.19268%
P/E RatioN/AN/A-
Revenue0591M-
Total Cash246M494M50%
Total Debt17.1M38.3M45%
FUNDAMENTALS RATINGS
COGT vs RARE: Fundamental Ratings
COGT
RARE
OUTLOOK RATING
1..100
6673
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
79
Overvalued
PROFIT vs RISK RATING
1..100
69100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
4060
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RARE's Valuation (79) in the Biotechnology industry is in the same range as COGT (82) in the Miscellaneous industry. This means that RARE’s stock grew similarly to COGT’s over the last 12 months.

COGT's Profit vs Risk Rating (69) in the Miscellaneous industry is in the same range as RARE (100) in the Biotechnology industry. This means that COGT’s stock grew similarly to RARE’s over the last 12 months.

COGT's SMR Rating (99) in the Miscellaneous industry is in the same range as RARE (100) in the Biotechnology industry. This means that COGT’s stock grew similarly to RARE’s over the last 12 months.

COGT's Price Growth Rating (40) in the Miscellaneous industry is in the same range as RARE (60) in the Biotechnology industry. This means that COGT’s stock grew similarly to RARE’s over the last 12 months.

COGT's P/E Growth Rating (100) in the Miscellaneous industry is in the same range as RARE (100) in the Biotechnology industry. This means that COGT’s stock grew similarly to RARE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
COGTRARE
RSI
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
77%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
73%
Momentum
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
76%
MACD
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
75%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
72%
Advances
ODDS (%)
Bullish Trend 12 days ago
83%
N/A
Declines
ODDS (%)
Bearish Trend 9 days ago
83%
Bearish Trend 12 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
71%
View a ticker or compare two or three
Interact to see
Advertisement
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RARE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ABLYX27.260.14
+0.52%
American Beacon Large Cap Value Y
ANFCX54.600.24
+0.44%
American Funds New Economy C
PIBQX18.320.05
+0.27%
PGIM Balanced R6
ASGTX5.200.01
+0.19%
Transamerica Small Cap Growth A
RGIAX10.27N/A
N/A
Russell Inv Global Infrastructure A

COGT and

Correlation & Price change

A.I.dvisor indicates that over the last year, COGT has been loosely correlated with HOFBF. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if COGT jumps, then HOFBF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COGT
1D Price
Change %
COGT100%
-3.14%
HOFBF - COGT
63%
Loosely correlated
N/A
TNFA - COGT
55%
Loosely correlated
+3.59%
XNCR - COGT
55%
Loosely correlated
-3.10%
IDYA - COGT
54%
Loosely correlated
-4.13%
CGON - COGT
53%
Loosely correlated
-0.46%
More

RARE and

Correlation & Price change

A.I.dvisor indicates that over the last year, RARE has been loosely correlated with CRNX. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if RARE jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RARE
1D Price
Change %
RARE100%
-2.43%
CRNX - RARE
52%
Loosely correlated
-0.10%
COGT - RARE
51%
Loosely correlated
-3.14%
DNLI - RARE
50%
Loosely correlated
-2.69%
RVMD - RARE
50%
Loosely correlated
-1.52%
NUVL - RARE
49%
Loosely correlated
+0.68%
More